Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Share price finally moving up
View:
Post by TechOne on Jan 10, 2022 3:44pm

Share price finally moving up

into the right range..  Hopefully, 0.40s and 0.50s are around the corner.. 

Although, with Covid surge in US and presssure at the hospitals, I for one am still kind of worried about the Trial that we get a timely launch on recruitment of patients as well as the Dialysis tests but for now hope it is sustained green next couple of months until we get an update from the company..
Comment by mercedesman on Jan 10, 2022 6:16pm
...but a long way to go before it gets into the right range..  Hopefully, a buck or two ( pre FDA approval) is around the corner... based on EBITDA multiples, need ( incl. for endotoxemic Covid patients) and the probabilities of Trial success.  With a highly infectious Omicron surge in US and short term presssure at the hospitals, I for one am not too worried about the Trial ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities